IGNE - Igene Biotechnology, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/200912/31/200812/31/200712/31/2006
Total Revenue3,957.9037,644.4772,286.73-
Cost of Revenue2,942.346,395.0621,681.632-
Gross Profit1,015.5631,249.415605.098-
Operating Expenses
Research Development1,851.1181,655.908983.61847.598
Selling General and Administrative1,225.9781,781.7971,131.0691,120.291
Non Recurring----
Others-2,086.166-2,086.166-1,576.701-1,660.519
Total Operating Expenses3,933.279,832.7672,219.61307.37
Operating Income or Loss24.633-2,188.2967.12-307.37
Income from Continuing Operations
Total Other Income/Expenses Net-165.38-1,802.647-1,966.193-2,124.54
Earnings Before Interest and Taxes24.633-2,188.2967.12-307.37
Interest Expense-97.52-2,028.46-2,211.219-2,107.91
Income Before Tax-140.747-3,990.937-1,899.073-2,431.91
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-140.747-3,990.937-1,899.073-2,431.91
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-140.747-3,990.937-1,899.073-2,431.91
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-140.747-3,990.937-1,899.073-2,431.91